RT @CochraneLibrary: Do antipsychotic medicines reduce agitated behaviour and psychotic symptoms in people with #Alzheimer's disease and v…

Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia - Mühlbauer, V - 2021 | Cochrane Library https://t.co/KYTvk8HEOR

¿Los medicamentos #antipsicóticos reducen el comportamiento agitado y los síntomas psicóticos en personas con enfermedad de #Alzheimer y #demencia vascular? https://t.co/VFJIMpelDD La nueva RS de @CochraneDCIG analiza la evidencia de 24 estudios https://t.

RT @CochraneLibrary: Do antipsychotic medicines reduce agitated behaviour and psychotic symptoms in people with #Alzheimer's disease and v…

RT @CochraneLibrary: Do antipsychotic medicines reduce agitated behaviour and psychotic symptoms in people with #Alzheimer's disease and v…

RT @CochraneLibrary: Do antipsychotic medicines reduce agitated behaviour and psychotic symptoms in people with #Alzheimer's disease and v…

RT @CochraneLibrary: Do antipsychotic medicines reduce agitated behaviour and psychotic symptoms in people with #Alzheimer's disease and v…

RT @Saludteca: Antipsicóticos para la agitación y la psicosis en personas con enfermedad de Alzheimer y demencia vascular https://t.co/sNR3…

RT @Saludteca: Antipsicóticos para la agitación y la psicosis en personas con enfermedad de Alzheimer y demencia vascular https://t.co/sNR3…

RT @CochraneLibrary: Do antipsychotic medicines reduce agitated behaviour and psychotic symptoms in people with #Alzheimer's disease and v…

Do antipsychotic medicines reduce agitated behaviour and psychotic symptoms in people with #Alzheimer's disease and vascular #dementia? https://t.co/Llfuu3lGhs New @CochraneDCIG systematic review looks at the evidence from 24 studies.

RT @Saludteca: Antipsicóticos para la agitación y la psicosis en personas con enfermedad de Alzheimer y demencia vascular https://t.co/sNR3…

Antipsicóticos para la agitación y la psicosis en personas con enfermedad de Alzheimer y demencia vascular https://t.co/sNR3AK9tgI 🩺Hay alguna evidencia de que los antipsicóticos típicos podrían disminuir ligeramente la agitación y la psicosis en los paci

(Cochrane) #Demencia Alguna evidencia que antipsicóticos típicos disminuyen agitación y psicosis. Atípicos reducen levemente agitación, pero efecto sobre psicosis es insignificante. Aparente eficacia práctica podría ser curso natural favorable de síntomas

RT @CochraneUK: Do antipsychotic medicines reduce agitated behaviour and psychotic symptoms in people with #Alzheimer's disease and vascula…

RT @CochraneUK: Do antipsychotic medicines reduce agitated behaviour and psychotic symptoms in people with #Alzheimer's disease and vascula…

RT @CochraneUK: Do antipsychotic medicines reduce agitated behaviour and psychotic symptoms in people with #Alzheimer's disease and vascula…

Antipsicóticos para la agitación y la psicosis en personas con enfermedad de Alzheimer y demencia vascular - Mühlbauer, V - 2021 | Cochrane Library https://t.co/WvNSBtZ13f

RT @NeurologyToday: Via @CochraneLibrary: Researchers assess the efficacy and safety of antipsychotics for the treatment of agitation and p…

RT @CochraneUK: Do antipsychotic medicines reduce agitated behaviour and psychotic symptoms in people with #Alzheimer's disease and vascula…

Do antipsychotic medicines reduce agitated behaviour and psychotic symptoms in people with #Alzheimer's disease and vascular #dementia? https://t.co/hjuIhV5vgc New @CochraneDCIG systematic review looks at the evidence from 24 studies. https://t.co/LldjCfej

RT @NeurologyToday: Via @CochraneLibrary: Researchers assess the efficacy and safety of antipsychotics for the treatment of agitation and p…

Summarizes 24 studies with a total of 6090 people. Essential reading to understand the evidence base.

RT @NeurologyToday: Via @CochraneLibrary: Researchers assess the efficacy and safety of antipsychotics for the treatment of agitation and p…

Via @CochraneLibrary: Researchers assess the efficacy and safety of antipsychotics for the treatment of agitation and psychosis in people with #AlzheimersDisease and #VascularDementia. https://t.co/mLoiY5BwGi https://t.co/SMiSzGSxfp

(Cochrane) Papel de los Antipsicóticos en el tratamiento de la agitación en pacientes con demencia ✅Efecto muy leve ✅Altos efectos adversos ✅Muchas veces el beneficio se atribuye al curso natural del proceso. #PorMasSalud https://t.co/OL7G0nVSRK https://

¿Los medicamentos antipsicóticos reducen los comportamiento agitados y los síntomas psicóticos en personas con enfermedad de #Alzheimer y #demencia vascular? https://t.co/ICSPQBpNiU La nueva revisión sistemática de @CochraneDCIG analiza la evidencia de 24

【BPSD】Systematic Review．Alzheimer or 血管性認知症の興奮or精神病症状に対する，(定型・非定型)抗精神病薬の治療効果に関するエビデンスはごくわずか．日常診療で見られる薬剤の有効性は，プラセボ群でも見られていた． https://t.co/zXbr3Ma28A

Compensa riesgos beneficios el uso de antipsicóticos en Alzheimer o en demencia vascular? #cohrane se van a sorprender...

RT @cochrane_nz: Do antipsychotic medicines reduce agitated behaviour and psychotic symptoms in people with #Alzheimer's disease and vascu…

Do antipsychotic medicines reduce agitated behaviour and psychotic symptoms in people with #Alzheimer's disease and vascular #dementia? https://t.co/5365NGHFsW New @CochraneDCIG systematic review looks at the evidence from 24 studies. https://t.co/BY1Kb34

RT @cochranecollab: Do antipsychotic medicines reduce agitated behaviour and psychotic symptoms in people with #Alzheimer's disease and va…

RT @cochranecollab: Do antipsychotic medicines reduce agitated behaviour and psychotic symptoms in people with #Alzheimer's disease and va…

Do antipsychotic medicines reduce agitated behaviour and psychotic symptoms in people with #Alzheimer's disease and vascular #dementia? https://t.co/n4kwvFFi5g New @CochraneDCIG systematic review looks at the evidence from 24 studies.

RT @KoepkeSascha: It took some time, but at last our review is out, hopefully influencing antipsychotic prescription practice in dementia:…

RT @CochraneDCIG: Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia Review published! htt…

RT @RMcNallyNHS: New mental health reviews from @CochraneLibrary available with a service user summary @SEdwardsNHS @PimlottBrenda Antipsy…

Thanks for the update @RMcNallyNHS. Always well worth keeping up with @CochraneLibrary and their gold standard systematic reviews. https://t.co/kD43UvhiaP

RT @CochraneDCIG: Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia Review published! htt…

RT @CochraneDCIG: Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia Review published! htt…

New mental health reviews from @CochraneLibrary available with a service user summary @SEdwardsNHS @PimlottBrenda Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia - Mühlbauer, V - 2021 | Cochrane Library

#Antipsychotics for agitation and #psychosis in people with #Alzheimer's disease and vascular dementia https://t.co/hp1nhtirzf

RT @CochraneDCIG: Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia Review published! htt…

RT @CochraneDCIG: Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia Review published! htt…

RT @CochraneDCIG: Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia Review published! htt…

RT @CochraneDCIG: Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia Review published! htt…

RT @KoepkeSascha: It took some time, but at last our review is out, hopefully influencing antipsychotic prescription practice in dementia:…

New article: Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia https://t.co/nZ7DBVZOVO #alzheimers #neurology https://t.co/gwUTDAmdBS

RT @CochraneDCIG: Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia Review published! htt…

RT @CochraneDCIG: Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia Review published! htt…

RT @CochraneDCIG: Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia Review published! htt…

RT @CochraneDCIG: Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia Review published! htt…

RT @CochraneDCIG: Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia Review published! htt…

RT @KoepkeSascha: It took some time, but at last our review is out, hopefully influencing antipsychotic prescription practice in dementia:…

RT @CochraneDCIG: Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia Review published! htt…

RT @KoepkeSascha: It took some time, but at last our review is out, hopefully influencing antipsychotic prescription practice in dementia:…

RT @KoepkeSascha: It took some time, but at last our review is out, hopefully influencing antipsychotic prescription practice in dementia:…

RT @KoepkeSascha: It took some time, but at last our review is out, hopefully influencing antipsychotic prescription practice in dementia:…

RT @KoepkeSascha: It took some time, but at last our review is out, hopefully influencing antipsychotic prescription practice in dementia:…

RT @KoepkeSascha: It took some time, but at last our review is out, hopefully influencing antipsychotic prescription practice in dementia:…

Great joint effort on the ( limited) efficacy of antipsychotics for agitation and psychosis in dementia. @UNO_UMCG @umcg

RT @CochraneDCIG: Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia Review published! htt…

Congratulations 🎉

It took some time, but at last our review is out, hopefully influencing antipsychotic prescription practice in dementia: https://t.co/JXyXSU2pWC @MartinDichter @SytseZuidema @DikaLuijendijk @CochraneDCIG @cochranecollab @UKKoeln @UniCologne

Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia Review published! https://t.co/gDJjksapTe #Alzheimers #AlzheimersDisease #Cochrane https://t.co/q44THhtJHF